Insider Transactions in Q2 2025 at Tandem Diabetes Care Inc (TNDM)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 29
2025
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
BUY
Other acquisition or disposition
|
Indirect |
11,200
+32.8%
|
-
|
|
May 29
2025
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
SELL
Other acquisition or disposition
|
Direct |
11,200
-100.0%
|
-
|
|
May 22
2025
|
Dick Allen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+18.45%
|
$87,740
$20.64 P/Share
|
|
May 22
2025
|
Joao Paulo Falcao Malagueira Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+26.85%
|
$87,740
$20.64 P/Share
|
|
May 22
2025
|
Christopher J Twomey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+21.87%
|
$87,740
$20.64 P/Share
|
|
May 22
2025
|
Peyton R Howell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+17.23%
|
$87,740
$20.64 P/Share
|
|
May 22
2025
|
Rebecca B Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+24.14%
|
$87,740
$20.64 P/Share
|
|
May 22
2025
|
Myoungil Cha Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+26.85%
|
$87,740
$20.64 P/Share
|
|
May 22
2025
|
Kathleen Mc Groddy Goetz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+19.73%
|
$87,740
$20.64 P/Share
|
|
May 22
2025
|
Rajwant Sodhi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,387
+22.04%
|
$87,740
$20.64 P/Share
|
|
May 15
2025
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,907
-2.13%
|
$63,954
$22.7 P/Share
|
|
May 15
2025
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,121
+5.28%
|
-
|
|
May 15
2025
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+4.54%
|
$20,385
$15.64 P/Share
|
|
May 15
2025
|
Jean Claude Kyrillos EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
171
+1.57%
|
$3,249
$19.3 P/Share
|
|
May 15
2025
|
John F Sheridan PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,470
-4.06%
|
$362,340
$22.7 P/Share
|
|
May 15
2025
|
John F Sheridan PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
32,429
+6.89%
|
$162,145
$5.68 P/Share
|
|
May 15
2025
|
John F Sheridan PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+1.66%
|
$20,385
$15.64 P/Share
|
|
May 15
2025
|
Rick Carpenter Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,014
-3.21%
|
$44,308
$22.7 P/Share
|
|
May 15
2025
|
Rick Carpenter Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,622
+8.01%
|
-
|
|
May 15
2025
|
Rick Carpenter Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,020
+5.53%
|
$15,300
$15.64 P/Share
|
|
May 15
2025
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,496
-7.34%
|
$76,912
$22.7 P/Share
|
|
May 15
2025
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,526
+11.16%
|
-
|
|
May 15
2025
|
Elizabeth Anne Gasser EVP, Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,147
+12.31%
|
$17,205
$15.64 P/Share
|
|
May 15
2025
|
Susan Morrison EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,868
-1.27%
|
$41,096
$22.7 P/Share
|
|
May 15
2025
|
Susan Morrison EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,526
+4.08%
|
-
|
|
May 15
2025
|
Susan Morrison EVP & Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+4.01%
|
$20,385
$15.64 P/Share
|
|
May 15
2025
|
Mark David Novara EVP & CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-0.45%
|
$2,486
$22.7 P/Share
|
|
May 15
2025
|
Mark David Novara EVP & CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
304
+1.19%
|
-
|
|
May 15
2025
|
Mark David Novara EVP & CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
870
+3.36%
|
$16,530
$19.3 P/Share
|
|
May 15
2025
|
Shannon Marie Hansen EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,275
-4.53%
|
$50,050
$22.7 P/Share
|
|
May 15
2025
|
Shannon Marie Hansen EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,355
+10.75%
|
-
|